General Information of DTT (ID: TTDM6HZ)

DTT Name Alpha-N-acetylglucosaminidase (NAGLU) DTT Info
Gene Name NAGLU

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Approved Drug(s)
Clinical Trial Drug(s)
1 Approved Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
N-Acetyl-D-glucosamine DM1XBWR Autoimmune diabetes 5A10 Approved [1]
------------------------------------------------------------------------------------
2 Clinical Trial Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
ABO-101 DMUBLC3 Mucopolysaccharidosis 5C56.3 Phase 1/2 [2]
BMN 250 DMM25B1 Mucopolysaccharidosis type IIIB 5C56.3Y Phase 1/2 [3]
------------------------------------------------------------------------------------
Molecule Interaction Atlas

References

1 Development of bFGF-Chitosan Matrices and Their Interactions with Human Dermal Fibroblast Cells. J Biomater Sci Polym Ed. 2009;20(10):1335-51.
2 Clinical pipeline report, company report or official report of Abeona Therapeutics.
3 Translational studies of intravenous and intracerebroventricular routes of administration for CNS cellular biodistribution for BMN 250, an enzyme replacement therapy for the treatment of Sanfilippo type B. Drug Deliv Transl Res. 2020 Apr;10(2):425-439.